Photodynamic Therapy for the Treatment of Basal Cell Carcinoma: A Comprehensive Review of Randomized Controlled Trials
Open Access
- 30 April 2024
- journal article
- research article
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 14 (2) , e2024105
Abstract
Introduction: Basal cell carcinoma (BCC) is the most common skin cancer worldwide and has been reported to have a rising incidence in the last years. Multiple therapeutic modalities are approved for the treatment of BCC, making it difficult for physicians to choose the most suitable option for every patient. Photodynamic therapy (PDT) using either 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) as photosensitizing agents is an established treatment option for low-risk BCC. Objectives: This review aims to summarize the available evidence from randomized clinical trials (RCTs) that utilize either ALA or MAL PDT and compare it with other treatment modalities. The main outcomes related to the effectiveness, adverse events, cosmetic outcomes and pain sensation, along with data from long-term follow-ups will be presented and discussed. Methods: Thorough literature searches were conducted through the electronic databases ClinicalTrials.gov and Pubmed/MEDLINE from inception up to 28 March 2023. Only studies in English were included. All relevant data were extracted accordingly from the eligible studies. Results: Eight RCTs included superficial BCC (sBCC) alone, 7 included nodular BCC (nBCC), 2 included both sBCC and nBCC and 1 included BCC of unspecified subtype. Follow-up duration ranged from 3 months to 5 years. Both ALA-PDT and MAL-PDT demonstrated acceptable efficacy, adverse events, cosmetic outcomes and pain sensation while no major differences were observed between them. PDT was less effective than surgery but with better reported cosmetic outcomes. Conclusions: PDT is a safe and efficacious treatment option for sBCC and to a lesser extent nBCC.Keywords
This publication has 57 references indexed in Scilit:
- Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationJournal of the American Academy of Dermatology, 2005
- Rapid and Continuous Increases in Incidence Rates of Basal Cell Carcinoma in the Southeast Netherlands Since 1973Journal of Investigative Dermatology, 2004
- Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell CarcinomaArchives of Dermatology, 2004
- Skin cancer is among the most costly of all cancers to treat for the Medicare populationJournal of the American Academy of Dermatology, 2003
- Variations of basal cell carcinomas according to gender, age, location and histopathological subtypeBritish Journal of Dermatology, 2002
- Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trialBritish Journal of Dermatology, 2001
- AGE AND SITE PREVALENCE OE HISTOLOGIC SUBTYPES OE BASAL CELL CARCINOMASInternational Journal of Dermatology, 1995
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Histologic pattern analysis of basal cell carcinomaJournal of the American Academy of Dermatology, 1990
- Photodynamic therapy with endogenous protoporphyrinJournal of Photochemistry and Photobiology B: Biology, 1990